SanBio Co (4592) Financial Statements

Compare

6 Followers

SanBio Co Financial Overview

SanBio Co's market cap is currently ¥146.70B. The company's EPS TTM is ¥; its P/E ratio is -35.18; SanBio Co is scheduled to report earnings on ―, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.

	Jan 26	Jan 25	Jan 25	Jan 24	Jan 23
Income Statement
Total Revenue	¥ 0.00	¥ 0.00	¥ 0.00	¥ 0.00	¥ 0.00
Gross Profit	¥ -8.05M	¥ -14.50M	¥ -9.37M	¥ -24.61M	¥ -132.47M
Operating Income	¥ -3.79B	¥ -4.54B	¥ -3.52B	¥ -7.90B	¥ -6.62B
EBITDA	¥ -3.79B	¥ -4.53B	¥ -3.51B	¥ -7.87B	¥ -6.49B
Net Income	¥ -3.84B	¥ -2.64B	¥ -2.88B	¥ -5.56B	¥ -4.68B
Balance Sheet
Cash & Short-Term Investments	¥ 15.08B	¥ 4.45B	¥ 2.92B	¥ 6.73B	¥ 4.56B
Total Assets	¥ 15.62B	¥ 5.05B	¥ 3.45B	¥ 7.05B	¥ 5.51B
Total Debt	¥ 1.24B	¥ 665.00M	¥ 397.00M	¥ 933.00M	¥ 2.52B
Net Debt	¥ -13.84B	¥ -3.79B	¥ -2.52B	¥ -5.80B	¥ -2.03B
Total Liabilities	¥ 2.02B	¥ 2.25B	¥ 1.68B	¥ 2.62B	¥ 3.48B
Stockholders' Equity	¥ 13.60B	¥ 2.79B	¥ 1.76B	¥ 4.43B	¥ 2.04B
Cash Flow
Free Cash Flow	¥ -3.84B	¥ -4.79B	¥ -3.62B	¥ -7.46B	¥ -6.61B
Operating Cash Flow	¥ -3.81B	¥ -4.78B	¥ -3.62B	¥ -7.45B	¥ -6.57B
Investing Cash Flow	¥ -231.04M	¥ -19.03M	¥ -4.27M	¥ -10.10M	¥ -66.26M
Financing Cash Flow	¥ 16.01B	¥ 2.38B	¥ 2.10B	¥ 9.46B	¥ -1.47B

Currency in JPY

SanBio Co Earnings and Revenue History

Income Statement >

SanBio Co Debt to Assets

Balance Sheet >

SanBio Co Cash Flow

Cash Flow >

SanBio Co Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >